Lack of an association between circulating adiponectin levels and risk of colorectal adenoma

Clinical Laboratory

Volumn 59, Issue 1-2, 2013, Pages 211-214

  Danese, Elisa ^a   Minicozzi, Anna Maria ^a   Montagnana, Martina ^a   De Manzoni, Giovanni ^a   Lippi, Giuseppe ^b   Guidi, Gian Cesare ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

Adiponectin; Body mass index; Colorectal adenoma

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; GLUCOSE; LIPID;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COLON BIOPSY; COLORECTAL ADENOMA; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; INFLAMMATION; LIFESTYLE; LIPID BLOOD LEVEL; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; RISK FACTOR; SEX DIFFERENCE; TUMOR VOLUME; WAIST CIRCUMFERENCE;

ADENOMA; ADIPONECTIN; AGED; ANTHROPOMETRY; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIFE STYLE; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 84874611487     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2012.120717     Document Type: Article

References (17)

1. Barb D, Williams CJ, Neuwirth AK, Mantzoros CS. Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am J Clin Nutr 2007;86:s858-66.
2. Petridou E, Mantzoros C, Dessypris N, et al. Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. J Clin Endocrinol Metab 2003;88:993-7. (Pubitemid 36337745)
3. Miyoshi Y, Funahashi T, Kihara S, et al. Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res 2003;9:5699-704. (Pubitemid 37499493)
4. Goktas S, Yilmaz MI, Caglar K, Sonmez A, Kilic S, Bedir S. Prostate cancer and adiponectin. Urology 2005;65:1168-72. (Pubitemid 40824911)
5. Wei EK, Giovannucci E, Fuchs CS, Willett WC, Mantzoros CS. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 2005;97:1688-94. (Pubitemid 41672235)
6. Erarslan E, Turkay C, Koktener A, Koca C, Uz B, Bavbek N. Association of visceral fat accumulation and adiponectin levels with colorectal neoplasia. Dig Dis Sci 2009;54:862-8.
7. Otake S, Takeda H, Suzuki Y, et al. Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance. Clin Cancer Res 2005;11:3642-6. (Pubitemid 40685579)
8. Yamaji T, Iwasaki M, Sasazuki S, Tsugane S. Interaction between adiponectin and leptin influences the risk of colorectal adenoma. Cancer Res 2010;70:5430-7.
9. Nakajima TE, Yamada Y, Hamano T, et al. Adipocytokines as new promising markers of colorectal rumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer. Cancer Sci 2010;101:1286-91.
10. Otake S, Takeda H, Fujishima S, et al. Decreased levels of plasma adiponectin associated with increased risk of colorectal cancer. World J Gastroenterol 2010;16:1252-7.
11. Kumor A, Daniel P, Pietruczuk M, Matecka-Panas E. Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients. Int J Colorectal Dis 2009;24:275-81.
12. Fukumoto J, Otake T, Tajima O, et al. Adiponectin and colorectal adenomas: Self Defense Forces Health Study. Cancer Sci 2008;99:781-6. (Pubitemid 351448083)
13. Chronis A, Thomopoulos K, Sapountzis A, et al. Adiposity factors are not related to the presence of colorectal adenomas. Clin Exp Gastroenterol 2011;4:257-61.
14. Bobe G, Murphy G, Rogers CJ, et al. Serum adiponectin, leptin, C-peptide, homocysteine, and colorectal adenoma recurrence in the Polyp Prevention Trial. Cancer Epidemiol Biomarkers Prev 2010;19:1441-52.
15. Danese E, Montagnana M, Minicozzi AM, et al. The role of resistin in colorectal cancer. Clin Chim Acta 2012;413:760-4.
16. Alberti KG, Eckel RH, Grundy SM, et al. International Diabetes Federation Task Force on Epidemiolo-gy and Prevention, National Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society and International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-5.
17. Fasshauer M, Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia 2003;46:1594-603. (Pubitemid 38005321)